MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Cancer
Interventions: DRUG: entinostat
Sponsor: National Institutes of Health Clinical Center (CC)
Collaborators: National Cancer Institute (NCI)